Matthew Yan
Stock Analyst at CLSA
(3.91)
# 1,880
Out of 5,099 analysts
45
Total ratings
61%
Success rate
13.7%
Average return
Main Sectors:
Stocks Rated by Matthew Yan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 9995 RemeGen Co., Ltd. | Reiterated: Buy | $136.90 → $144.80 | $65.60 | +120.73% | 6 | Aug 25, 2026 | |
| HKG: 1801 Innovent Biologics, Inc. | Reiterated: Buy | $120.10 | $80.25 | +49.66% | 17 | Dec 8, 2025 | |
| HKG: 6160 BeOne Medicines AG | Reiterated: Buy | $264.40 → $288.00 | $220.80 | +30.43% | 10 | Nov 7, 2025 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Reiterated: Buy | $548.60 | $411.60 | n/a | 3 | Oct 19, 2025 | |
| HKG: 9606 Duality Biotherapeutics, Inc. | Initiated Coverage: Buy | $268.30 | $102.60 | n/a | 1 | May 22, 2025 | |
| ONC BeOne Medicines AG | Reiterated: Buy | $270 → $263 | $355.00 | n/a | 3 | Nov 13, 2024 | |
| TYO: 4568 Daiichi Sankyo Company, Limited | Reiterated: Buy | ¥6,800 → ¥7,000 | ¥2,877 | n/a | 4 | Oct 31, 2024 | |
| HKG: 0013 HUTCHMED (China) Limited | Reiterated: Buy | $41.00 | $20.70 | n/a | 1 | Aug 3, 2023 |
RemeGen Co., Ltd.
Aug 25, 2026
Reiterated: Buy
Price Target: $136.90 → $144.80
Current: $65.60
Upside: +120.73%
Innovent Biologics, Inc.
Dec 8, 2025
Reiterated: Buy
Price Target: $120.10
Current: $80.25
Upside: +49.66%
BeOne Medicines AG
Nov 7, 2025
Reiterated: Buy
Price Target: $264.40 → $288.00
Current: $220.80
Upside: +30.43%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Oct 19, 2025
Reiterated: Buy
Price Target: $548.60
Current: $411.60
Upside: n/a
Duality Biotherapeutics, Inc.
May 22, 2025
Initiated Coverage: Buy
Price Target: $268.30
Current: $102.60
Upside: n/a
BeOne Medicines AG
Nov 13, 2024
Reiterated: Buy
Price Target: $270 → $263
Current: $355.00
Upside: n/a
Daiichi Sankyo Company, Limited
Oct 31, 2024
Reiterated: Buy
Price Target: ¥6,800 → ¥7,000
Current: ¥2,877
Upside: n/a
HUTCHMED (China) Limited
Aug 3, 2023
Reiterated: Buy
Price Target: $41.00
Current: $20.70
Upside: n/a